Immune Response towards COVID-19
- 1 December 2021
- journal article
- Published by SciRes Literature LLC in Journal of Biomedical Research & Environmental Sciences
- Vol. 2 (12), 1197-1201
- https://doi.org/10.37871/jbres1372
Abstract
Background: As the world witnessed the outbreak of coronavirus illness 2019 (COVID-19), a disorder developed as a result of a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), increasing genetics with healthcare evidence suggest a corresponding leadership to SARS as well as the Middle East Respiratory Syndrome (MERS). Aim: The aim of this review is to highlight Immune response of human body toward COVID-19. Materials and methods: This was a narrative review. A comprehensive literature search was done using PubMed, Google Scholar, Scopus, and EMBASE using the keywords, Immune Response; COVID-19; Vaccination; SARS-Cov-2; ACE2; Coronavirus; MERS. Results: A flow of viral components passes to the body by means of nostrils, mouth and eyes. SARS-CoV-2 is in a position to continue to become unnoticed extended than numerous influenza or coronaviruses. Its proteins can accomplish entry by unlocking the Angiotensin-Converting Enzyme 2 (ACE2) protein in the lung cells; viruses also possess antigens furthermore recognize that these are what cries the immunity into movement via making antibodies. Investigators demonstrate an extensive variety of immune cells respond to COVID-19 along with valuable source retrieval, discovering that might want to notify the manufacturing of a viable vaccination. Conclusion: The body's natural response to a viral infection is a non-invasive intrinsic response in which macrophages, neutrophils, and dendritic cells limit the virus's progression and may even prevent it by multiplying symptoms. This non-invasive solution is accompanied by an elastic response in which the body produces radicals that primarily adjust to the herpes virus.Keywords
This publication has 13 references indexed in Scilit:
- Disposable face masks and reusable face coverings as non-pharmaceutical interventions (NPIs) to prevent transmission of SARS-CoV-2 variants that cause coronavirus disease (COVID-19): Role of new sustainable NPI design innovations and predictive mathematical modellingScience of The Total Environment, 2021
- Protective immunity against COVID-19: Unravelling the evidences for humoral vs. cellular componentsTravel Medicine and Infectious Disease, 2020
- SARS‐CoV‐2: Mechanism of infection and emerging technologies for future prospectsReviews in Medical Virology, 2020
- Aerosol transmission of SARS-CoV-2: The unresolved paradoxTravel Medicine and Infectious Disease, 2020
- Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19Allergy, 2020
- Host Immune Response and Immunobiology of Human SARS-CoV-2 InfectionPublished by Springer Science and Business Media LLC ,2020
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in miceScience Translational Medicine, 2020
- The 2019–2020 novel coronavirus (severe acute respiratory syndrome coronavirus 2) pandemic: A joint american college of academic international medicine-world academic council of emergency medicine multidisciplinary COVID-19 working group consensus paperJournal of Global Infectious Diseases, 2020
- Working with the psychological effects of trauma: consequences for mental health‐care workers – a literature reviewJournal of Psychiatric and Mental Health Nursing, 2003
- Major Histocompatibility Complex (MHC) Class I Recognition by Natural Killer CellsCritical Reviews™ in Immunology, 1997